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Summary
 
The retinoblastoma (RB)/p16
 
INK4a
 
 pathway regulates senes-
cence of human melanocytes in culture and oncogene-
induced senescence of melanocytic nevi 
 
in vivo
 
. This
senescence response is likely due to chromatin modifica-
tions because RB complexes from senescent melanocytes
contain increased levels of histone deacetylase (HDAC)
activity and tethered HDAC1. Here we show that HDAC1
is prominently detected in p16
 
INK4a
 
-positive, senescent
intradermal melanocytic nevi but not in proliferating,
recurrent nevus cells that localize to the epidermal/
dermal junction. To assess the role of HDAC1 in the
senescence of melanocytes and nevi, we used tetracycline-
based inducible expression systems in cultured melano-
cytic cells. We found that HDAC1 drives a sequential and
cooperative activity of chromatin remodeling effectors,
including transient recruitment of Brahma (Brm1) into
RB/HDAC1 mega-complexes, formation of heterochromatin
protein 1β β β β
 
 (HP1β β β β
 
)/SUV39H1 foci, methylation of H3-K9,
stable association of RB with chromatin and significant
global heterochromatinization. These chromatin changes
coincide with expression of typical markers of senescence,
including the senescent-associated β β β β
 
-galactosidase marker.
Notably, formation of RB/HP1β β β β
 
 foci and early tethering of
RB to chromatin depends on intact Brm1 ATPase activity.
As  cells reached senescence, ejection of Brm1 from
chromatin coincided with its dissociation from HP1β β β β
 
/RB
and relocalization to protein complexes of lower mole-
cular weight. These results provide new insights into the
role of the RB pathway in regulating cellular senescence
and implicate HDAC1 as a likely mediator of early chromatin
remodeling events.
Key words: Brm1; HDAC1; human melanocytes; melanocytic
nevi; melanoma; RB.
 
Introduction
 
Senescence has been implicated 
 
in vivo
 
 as a tumor-suppression
mechanism in many cell types (Braig 
 
et al
 
., 2005; Chen 
 
et al
 
.,
2005; Collado 
 
et al
 
., 2005; Michaloglou 
 
et al
 
., 2005). Melano-
cytes, the cell type from which melanoma arises, are specialized
cells that synthesize and transfer the pigment melanin to
surrounding keratinocytes, leading to skin pigmentation and
protection against solar exposure. Progressive melanocyte
dysfunction with aging may be associated with the dramatic
increase in melanoma and nonmelanoma skin cancers in older
individuals (Desai 
 
et al
 
., 2006). Activating mutations of B-RAF
trigger melanocyte proliferation and formation of melanocytic nevi
(moles) (Pollock 
 
et al
 
., 2003). However, further proliferation and
risk of acquiring additional mutations is curtailed by the activation
of the retinoblastoma (RB)/p16
 
INK4a
 
 but not the p53/p21 or p14
 
ARF
 
pathways (Michaloglou 
 
et al
 
., 2005) resulting in irreversible
growth arrest of normal melanocytic nevi and senescence.
There are at least two different senescence mechanisms in
human cells, a telomere-dependent pathway that is regulated
by ATM/p53/p21 and a telomere-independent one often regu-
lated by p16
 
INK4a
 
/RB (also referred to stasis). The RB family of
proteins can induce repressive chromatin states around euchro-
matic promoters and have a direct role in the assembly of
pericentric and telomeric heterochromatin domains (Gonzalo
& Blasco, 2005). For example, Rb maintains histone H4 lysine
20 trimethylation (triMeH4K20) at constitutive heterochromatin
domains (Gonzalo 
 
et al
 
., 2005). Recent experimental evidence
suggests that RB is a critical regulator of epigenetic changes
during cellular senescence of melanocytes and fibroblasts
(Bandyopadhyay 
 
et al
 
., 2002; Narita 
 
et al
 
., 2003). These data
support an hypothesis proposed more than a quarter of century
ago stating that aging of proliferating cells may result from
genome reorganization occurring during the division cycle
(Macieira-Coelho, 1980). RB represses E2F transcription factors
by recruiting chromatin remodeling proteins including histone
deacetylases (HDAC) and SWI/SNF complexes (Ferreira 
 
et al
 
.,
2001). Genetic studies in flies revealed that the HDACs Rpd3,
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an HDAC1 homolog (Johnson & Turner, 1999), and Sir2 have
opposing effects in organismal lifespan; haploinsufficiency of
Rpd3 extends Drosophila longevity by increasing the levels of
Sir2 (Rogina 
 
et al
 
., 2002) whereas greatly reduced levels of Rpd3
result in lethality (Mannervik & Levine, 1999).
Additional data supporting the role of chromatin remodeling
in senescence of melanocytes include evidence that changes in
p300 HDAC activity by overexpression of a dominant negative
p300 protein or treatment with Lys-CoA (a specific chemical
inhibitor of p300 HAT) result in early senescence of normal
melanocytes, and surprisingly, also of melanoma cells (Bandy-
opadhyay 
 
et al
 
., 2002). These studies suggested a model by
which imbalances in the steady state ratio of HAT/HDAC induce
extensive chromatin remodeling resulting in growth inhibition
and cellular senescence (Bandyopadhyay 
 
et al
 
., 2002).
Assembly of protein complexes in chromatin requires the
use of adenosine triphosphate (ATP) as a source of energy to
remodel nucleosomes (Johnson 
 
et al
 
., 2005). Such energy can
be provided by a variety of chromatin remodeling complexes
including SWI/SNF, nucleosome remodeling factor (NURF),
chromatin accessibility complex (CHRAC), and ATP-dependent
chromatin-assembly factor (ACF). Brahma-related gene 1 (Brg1)
and Brahma (Brm1) are two members of SWI/SNF complexes
that contain a highly conserved ATPase domain and a C-terminal
bromodomain. Evidence implicating members of SWI/SNF chro-
matin remodeling complexes in aging is limited but suggestive.
For example, Brg1/RB complexes can induce cell cycle arrest
(Dunaief 
 
et al
 
., 1994) and a senescent-like morphology in the
human adrenal cortex carcinoma-derived cell line SW13
(Shanahan 
 
et al
 
., 1999). More significantly, repressive com-
plexes containing Brm1, RB, and C/EBP
 
α
 
 regulate liver aging in
mice (Iakova 
 
et al
 
., 2003). In this work, we present evidence that
increased HDAC1 levels and activity initiate a sequential and
cooperative assembly of chromatin effector proteins leading
to the formation of early, transient Brm1/RB/Hp1
 
β
 
 complexes,
stable association of RB with chromatin, formation of RB/HP1
 
β
 
and  HP1
 
β
 
/SUV39h1 foci, progressive heterochromatinization,
and ultimately irreversible cell cycle arrest and senescence.
 
Results
 
HDAC1 drives senescence in melanocytic cells
 
Human intradermal melanocytic nevi are essentially senescent
entities resulting from the oncogenic activation and limited
proliferation of melanocytes by mutated, constitutively active
BRAF
 
E600
 
 kinase (Michaloglou 
 
et al
 
., 2005). In contrast, recurrent
melanocytic nevi are proliferations of cytologically atypical
melanocytes localized to the epidermis and organized as nests
and as single cells with areas of upward epidermal migration.
These lesions may contain residual senescent melanocytic nevi
adjacent to the area of recurrence. Thus, recurrent melanocytic
nevi provide a unique 
 
in vivo
 
  system to study proliferating
melanocytes that have escaped cellular senescence and have re-
entered the cell cycle.
High levels and activity of HDAC1 associate with RB com-
plexes in senescent melanocytes and are responsible for silen-
cing the 
 
cyclin E
 
 gene in these cells (Bandyopadhyay 
 
et al
 
., 2002).
To determine whether HDAC1 expression is associated with
senescence of melanocytic nevi 
 
in vivo
 
 and normal melanocytes
in culture, we used immunohistochemistry in human specimens
of recurrent melanocytic nevi. We show that cyclin A positive,
proliferating melanocytes localized along the dermal–epidermal
junction did not display detectable HDAC1 immunoreactivity
(Fig. 1A and third and fourth rows ‘recurrent nevi’). Differenti-
ating, HDAC1-positive keratinocytes in the epidermal (E) layer
served as an internal control for antibody immunoreactivity. In
contrast, the residual, cyclin A negative, dermal nests of melano-
cytes (D) demonstrated prominent nuclear HDAC1 staining in
foci-like structures. These results are consistent with previous
data showing that HDAC1 is a potent cyclin A repressor
(Stiegler 
 
et al
 
., 1998). Staining with an anti-p16
 
INK4a
 
 antibody
demonstrated scattered, weak immunoreactivity in recurrent
nevus cells whereas a strong, diffuse nuclear and cytoplasmic
immunoreactivity (Gray-Schopfer 
 
et al
 
., 2006; Nilsson & Landberg,
2006) was observed in the residual dermal nests of melanocytes
(Fig. 1A, last row). In agreement with previous data (Michaloglou
 
et al
 
., 2005), we were unable to detect p21
 
Waf1
 
 in the senescent
nevi (data not shown).
To investigate whether HDAC1 affects the onset and/or
maintenance of senescence, we used a tetracycline regulated
HDAC1-inducible system. Engineering adequate HDAC1 regu-
lation and studying its consequences is not feasible in normal
human melanocyte cultures that are capable of only 12–14
population doublings before the onset of senescence (Bennett
& Medrano, 2002). Therefore, we used the melanoma cell line
UCD-Mel-J, as it expresses wild-type p53 and RB, but does
not express p16
 
INK4a
 
 (E. E. Medrano, unpublished results). The
Tet-regulated UCD-derivative (UCD-HDAC1) cell line expressed
HDAC1 when treated with doxycycline (Dox), a potent tetracy-
cline analog (Fig. 1B). HDAC1 induction was not observed after
Dox treatment of cells transfected with an empty vector. Total
HDAC activity also increased after addition of 2 
 
µ
 
g mL
 
–1
 
 Dox
(Supplementary Fig. S1-A); thus, the ectopically expressed
HDAC1 was enzymatically proficient. An MTT-cell proliferation
assay demonstrated that 10–14 days after HDAC1 induction,
UCD-HDAC1 cells became growth arrested (Fig. 1C, blue line),
whereas uninduced UCD-HDAC1 cells, or UCD cells harboring
an empty vector in the presence or absence of Dox, displayed
normal exponential growth (Fig. 1C, gray, red, and green lines,
respectively). A bromodeoxyuridine incorporation assay con-
firmed that induction of HDAC1 paralleled a concomitant
decrease in the number of cells in the S phase of the cell cycle
(Supplementary Fig. S1-B).
After 3 weeks of sustained HDAC1 levels the cells became
irreversibly arrested (Fig. 1D). These cells did not resume growth
upon Dox removal (Supplementary Fig. S1-C), and continued
to display typical markers of normal melanocyte senescence
(Bennett & Medrano, 2002) including expression of the senescent-
associated 
 
β
 
-galactosidase (SA-
 
β
 
-gal) marker (Fig.  1D), a flat 
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Fig. 1 Overexpression of HDAC1 results in expression of senescent makers in vitro and correlates with senescence of intradermal melanocytic nevi in vivo. 
(A) HDAC1 is prominently detected in residual, senescent nevi but not in proliferating recurrent nevi. Melan-A highlights recurrent melanocytes in the epidermis 
and residual dermal nests of melanocytes (left and right column, first row). Note the positive staining of normal intra-epidermal melanocytes with Melan-A 
along the dermal–epidermal (right column, first row, red arrow). Recurrent melanocytic nevus show confluent proliferation of atypical melanocytes in the 
epidermis along the dermal–epidermal junction (E) and underlying scar tissue in the dermis (D, left column). Corresponding residual dermal nests of 
nevomelanocytes are located adjacent to the scar tissue and separated from the area of recurrence (D, right column). Recurrent nevi and scattered basal 
keratinocytes exhibit cyclin A immunoreactivity whereas the residual nevi are virtually cyclin A negative. There is absence of HDAC1 staining in the recurrent 
nevus cells along the dermal–epidermal junction (a white line was drawn to highlight a nevus nest) compared to the nuclear expression of HDAC1 in epidermal 
keratinocytes, which serve as a positive internal control (left column, third row). A higher magnification of recurrent melanocytes confirms that the nuclei of 
the recurrent nevi are essentially HDAC1 negative. Brown arrows highlight melanin pigment (left column, fourth row). In contrast, residual dermal nests of 
nevomelanocytes display positive nuclear immunoreactivity for HDAC1 in foci-like structures (right column, third and fourth row and insert). p16
INK4a staining 
demonstrated focal weak immunoreactivity in the recurrent nevi (left column, last row and insert) compared to strong nuclear and cytoplasmic expression 
staining in the residual nevus cells (right column, last row and insert). Virtually identical results were obtained in two additional sets of recurrent/residual nevi 
and in three independent intradermal melanocytic nevi. (B) Western blot showing inducible HDAC1 levels by the Tet-On system in UCD-Mel-N melanoma cell 
line. Numbers above the figure indicate Dox concentrations. (C) Growth curves of UCD-Empty vector control and UCD-HDAC1 cells before and after treatment 
with Dox. (D) Induction of the SA-β-gal marker in irreversibly quiescent cells 3 week after HDAC1 induction. Software enhancement of color was used to show 
the cell morphology of the SA-β-gal-negative cells in the inserts of the right and left upper figures. (E) Senescence induced by HDAC1 reproduces features of 
normal melanocyte senescence. Protein extracts from cells were electrophoresed, transferred to nitrocellulose and probed with the antibodies shown in the 
figure. PD, population doublings; S, senescent melanocytes (normal melanocytes usually senesce after 12–14 PD). 
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morphology, and aberrant cytokinesis (presence of multinucleated
cells; data not shown).
Paradoxically, HDAC1 can negatively regulate transcription of
a number of cell cycle genes associated with proliferation as well
as tumor suppression. Chromatin immunoprecipitation (ChIP)
assays previously demonstrated that silencing of the 
 
cyclin E
 
gene is associated with binding of HDAC1 complexes to its
promoter in senescent melanocytes (Bandyopadhyay 
 
et al
 
.,
2002). HDAC1 is also a negative regulator of p27
 
KIP-1
 
 (Lagger 
 
et al
 
.,
2002) and p53 (Ito 
 
et al
 
., 2002; Lagger 
 
et al
 
., 2003) transcription.
HDAC1-induced senescence (Fig. 1E) faithfully reproduced the
down-regulation of cyclin E, p53, and p27
 
KIP-1
 
 previously observed
during normal melanocyte senescence (Bandyopadhyay 
 
et al
 
.,
2001; Bennett & Medrano, 2002). Senescent melanocytic nevi
do not display telomere attrition and do not show evidence
for up-regulation of p53 or p21
 
Waf-1
 
 (Michaloglou 
 
et al
 
., 2005).
Similarly, HDAC1 did not elicit appreciable changes in telomerase
activity (Supplementary Fig. S1-E). This suggests that loss of
telomerase-mediated telomere elongation was not a proliferation-
limiting event in UCD-HDAC1 cells.
 
HDAC1-induced signatures of progressive 
heterochromatinization: formation of Rb/HP1β β β β
 
 and 
HP1β β β β
 
/SUV39H1 nuclear foci, trimethylation of H3-K9, 
and stable association of Rb with chromatin
 
Senescent fibroblasts display heterochromatic structures named
senescence-associated heterochromatic foci (SAHF) (Narita 
 
et al
 
.,
2003), which contain the histone variant macro H2A (Zhang
 
et al
 
., 2005). Formation of such structures coincides with the
recruitment of RB into protein complexes containing the hetero-
chromatin 1 binding protein 1
 
γ
 
 (HP1
 
γ
 
) (Narita 
 
et al
 
., 2003; Zhang
 
et al
 
., 2007). We found that senescent normal human melano-
cytes displayed prominent HP1
 
β
 
 foci compared to the nucleoplasm-
dispersed HP1
 
β
 
 in proliferating cells (Supplementary Fig. S2).
Overexpression of HDAC1 induced nuclear HP1
 
β
 
 foci in a dose-
and time-dependent manner (Fig. 2A,B). Formation of HP1
 
β
 
 foci
was HDAC1 dependent, as no foci were observed after treating
vector-only cells with Dox (data not shown). As the transition
from euchromatin to heterochromatin is gradual and requires
multiple cell divisions (Katan-Khaykovich & Struhl, 2005), early
formation of a relatively low number of HP1
 
β
 
 foci in the pro-
liferative phase after HDAC1 induction (Fig. 2B – ‘3 days’)
likely represents chromatin remodeling events and not SAHFs.
Conversely, presence of a large number of HP1
 
β
 
 foci (Fig. 2B
– ‘3 weeks’) may be indicative of higher order chromatin struc-
tures present in the senescent cells (Taddei 
 
et al
 
., 2005, 2006).
DNA from 
 
ras
 
-induced senescent fibroblasts (Narita 
 
et al
 
., 2003),
or from normal senescent melanocytes, displays increased resist-
ance to micrococcal nuclease digestion compared to proliferating
cells (Fig. 2C, left panel). An 
 
in vitro
 
 assay (Fig. 2C, right panel)
demonstrated that HP1
 
β
 
 displayed increased association with
chromatin. A cell-based assay indicated that both RB and HP1
 
β
 
became strongly tethered with chromatin in the senescent
cells (Fig. 2D). Importantly, these results are independent of the
respective protein levels; RB protein levels decrease whereas
HP1
 
β
 
 does not change in the senescent cells compared to the
uninduced proliferating cells (Fig. 4B).
Rb interacts with HDAC1 through the ‘pocket’ domain result-
ing in modifications of the chromatin structure (Brehm 
 
et al
 
.,
1998). RB is necessary to direct methylation of histone H3-K9
by the histone methyltransferase SUV39H1 (Nielsen 
 
et al
 
., 2001).
In turn, recruitment of HP1 proteins to chromatin requires H3-
K9 methylation and direct protein–protein association between
SUV39H1 and HP1 (Stewart 
 
et al
 
., 2005). Induction of HDAC1
resulted in the rapid redistribution and colocalization of SUV39H1
and HP1
 
β
 
 in nuclear foci, whereas proliferating cells mostly
displayed unstructured localization of both proteins (Fig. 3A).
HDAC1 also favored H3-K9 di- and trimethylation (Fig.  3B).
These events, which are consistent with features of heterochro-
matinization in skin fibroblasts from aging baboons (Herbig
 
et al
 
., 2006), are likely mediated by the direct association of
HDAC1 with SUV39H1 (Vaute 
 
et al
 
., 2002). Methylation of H3-
K9 appears to be a two-phase dynamic event associated with
HDAC1 induction (Fig.  3B). Whereas dimethylation followed
rapid kinetics and correlated with formation of HP1
 
β
 
/SUV39H1
foci, trimethylation of H3-K9 occurred with slower kinetics and
only reached a plateau in senescent cells. These data suggest
that H3-K9 trimethylation may be regulated by another histone
methyltransferase in the senescent cells, or alternatively, by a
different set of proteins regulating SUV39H1 activity at the
onset of senescence. Finally, extensive heterochromatinization
after prolonged HDAC1 induction may explain the irreversibility
of the senescent state upon Dox removal, as most histone
acetyltransferases will not have access to the higher order
chromatin regions.
 
Transient association of Brm1 with Rb and HP1β β β β
 
 
precedes growth inhibition driven by HDAC1
 
The repressive functions of RB require its association with several
proteins including HDAC1 (Brehm 
 
et al
 
., 1998; Magnaghi-Jaulin
 
et al., 1998), HP1 (Nielsen et al., 2001), and Brm1 (Trouche
et al., 1997). To molecularly define the role of RB-associated
proteins during senescence driven by HDAC1, we analyzed
changes in expression and protein–protein associations of Brm1,
RB, and HP1β before and after Dox treatments. HDAC1 initiated
a rapid distribution of nucleoplasmic RB into nuclear foci,
colocalizing with HP1β (Fig. 4A). Total levels of Brm1 and RB
declined rapidly after HDAC1 induction, an event that was
even more pronounced in the senescent cells (Fig. 4B). Notably,
immunoprecipitation with an HP1β antibody showed a dramatic
and transient association of Brm1 with Rb and HP1β (Fig. 4B,
left panel), whereas immunoprecipitation with an HDAC1 anti-
body showed a time-dependent increase of both Brm1 and RB
association with HDAC1 (Fig. 4B, right panel). Limited amounts
of BRM1 associated with HDAC1 suggest that the bulk of
this protein associated with complexes containing HP1β (Fig. B,
left panel). Glutathione S-transferase (GST) pull-down assays
showed that RB strongly interacts with HDAC1 in senescentHDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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Fig. 2 Overexpression of HDAC1 triggers a time-dependent increase in HP1β foci and association of RB and HP1β with chromatin. (A) HDAC1-induced cells 
show formation of HP1β foci in a dose-dependent manner. The cells were processed for immunocytochemistry 3 days after Dox treatments. (B) HDAC1 induces 
HP1β foci in a time-dependent manner. The experiments shown herein and in subsequent figures used 2 µg mL
–1 Dox to induce HDAC1. (C) Increased affinity 
of HP1β with senescent chromatin. Left panel: chromatin from senescent melanocytes shows increased resistance to micrococcal nuclease (MNase) digestion 
(see Experimental procedures). Right panel: an in vitro assay (Experimental procedures) using MNase-digested chromatin with a size range of 146 bp–2 kbp 
demonstrated that HP1β has increased affinity for senescent chromatin. (D) A cell-based assay (Experimental procedures) confirmed and extended results from 
the in vitro assay by showing that HDAC1 increases the association of both HP1β and RB with chromatin. M, DNA marker. T.E., total protein extract from 
uninduced UCD-HDAC1 cells. Right panel: Ponceau red staining indicating protein loading.HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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melanocytes (Fig. 4C, upper panel), whereas it associates with
Brm1 in proliferating cells but only minimally in senescent cells
(Fig. 4C, bottom panel). A coomasie gel (Fig. 4C, middle panel)
indicated GST-RB protein expression. We noticed that the Brm1
antibody detected a prominent doublet in proliferating melano-
cytes and UCD-HDAC1 cells. Such a doublet, which was also
detected by a different Brm1 antibody in NIH3T3 cells (Harikrishnan
et al., 2005), could indicate Brm1 post-translational modifications.
Two negative controls demonstrated the specificity of the GST
assays. A RB mutant lacking 14 of the 15 conserved cyclin-
dependent kinase consensus phosphorylation sites (RB-NPC)
(Chew et al., 1998) showed negligible association with Brm1
compared to wild-type RB. This suggests that as cells senesce,
dephosphorylation of RB (Fig. 4B) impairs its binding to Brm1.
A second RB mutant (RB∆LXCXE) confirmed that the LXCXE
binding pocket is required for the association of RB with Brm1
(Trouche et al., 1997). In conclusion, the GST pull-down assays
in normal senescent melanocytes support the findings using the
HDAC1-inducible model in melanoma cells (Fig. 4B).
To define the kinetics of Brm1 complex formation, we used
size exclusion chromatography and Western blotting with
antibodies to Brm1, RB, and HP1β. In uninduced cells, HP1β
migrated mostly as a monomer, whereas Brm1 was widely
distributed indicating that this protein forms multiprotein
complexes with diverse partners (Fig. 5A). Induction of HDAC1
elicited a rapid redistribution of Brm1, HP1β, and RB to high
molecular weigh fractions (Fig. 5B). Immunoprecipitation with
an HP1β antibody (Fig. 5C) confirmed the association of HP1β
with RB and Brm1. This mega-complex likely contains additional
proteins as the sum of the molecular weights of Brm1, HP1β,
and RB (~310  kDa) is significantly lower than that of the
observed complex (~1 × 10
6 kDa). Significantly, this high mole-
cular weight complex, which was formed when the cells were
still proliferating (Fig. 1B), was undetectable in the senescent
cells (Fig. 5D). At this time, the bulk of RB had moved to lower
molecular weight fractions (~680  kDa), partially colocalizing
with Brm1 and HP1β. Together, these experiments suggest that
the recruitment of RB to protein complexes is a dynamic, time-
dependent event mediated by the increased activity of HDAC1.
Transient expression of a dominant negative Brm1 
(dnBrm1) prevents the association of RB and HP1β β β β with 
chromatin and formation of HP1β β β β nuclear foci
To test whether transient formation of the Brm1/RB/HP1β
complex coincides with the association of Brm1 with chromatin,
cells were induced to express HDAC1 for 2 days and 3 weeks.
Brm1 strongly, though transiently, associated with chromatin
after HDAC1 induction (Fig. 6A, right panel). Yet, in contrast
with the stable association of RB with chromatin (compare
Fig. 2D with 6B), Brm1 was minimally detected in the chromatin
of senescent cells. Interestingly, Brg1, a Brm1-related ATPase,
showed minimal association with chromatin. Together, the
results suggest that the chromatin-remodeling activity of Brm1
is an early event likely required for nucleosomal remodeling
in preparation for trimethylation of H3-K9 and irreversible
heterochromatinization. Thus, it is likely that Brm1 activity may be
dispensable for the maintenance of repressive heterochromatin.
Notably, a similar exclusion of Brm1 from condensed chromatin
operates in mitotic cells (Muchardt et al., 1996). Stable recruit-
ment of HP1 to chromatin requires two interactions: association
of HP1 with methylated H3-K9 and direct protein–protein
interaction between HP1 and SUV39H1 (Stewart et al., 2005).
Increased HDAC1 activity leads to elevated HP1β recruitment
to chromatin in a time-dependent manner that peaked in the
senescent cells (Fig. 6A). It has been previously shown that the
three HP1 proteins (α, β, and γ) localize to DNA foci in senescent
fibroblasts (Narita et al., 2003). However, neither HP1α  nor
HP1γ  showed appreciable changes in chromatin association
after HDAC1 induction (Fig. 6A) in melanoma cells.
To test whether the ATP-dependent chromatin-remodeling
activity of Brm1 is required for the transient association of RB
Fig. 3 HDAC1 induces features of heterochromatinization. (A) Colocalization 
of HP1β and SUV39H1 in nuclear foci. UCD-HDAC1 cells were left untreated 
or treated with 2 µg mL
–1 doxycline for 2 days, fixed and processed for 
immunofluorescence using HP1β and SUV39H1 as described in Experimental 
procedures. The boxes indicate areas zoomed (bottom figures) to show 
colocalization of HP1β with SUV39H1. (B) HDAC1 induces deacetylation of 
H4 and H3, and di- and trimethylation of H3-K9. 2MeK9-H3, dimethylated 
K9 on histone H3; 3MeK9-H3, trimethylated K9 on histone H3.HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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and HP1β to chromatin, we transfected an empty vector control,
a dominant negative, ATPase-dead Brm1 (dnBRM1) mutant that
lacks chromatin-remodeling activity (Bourachot et al., 1999) or
dnBrm1 plus Brg1, in UCD-HDAC1 cells before or after induc-
tion of HDAC1 for 2 days. Remarkably, the dnBRM1 mutant
almost completely prevented the association of both RB and
HP1β with chromatin (compare Fig. 6B, lane 4 with lane 2).
Consistent with previous results showing that Brg1 and Brm
complexes regulate distinct cellular processes through protein–
protein interactions that are specific for each ATPase (Kadam
& Emerson, 2003), cotransfection of dnBrm1 with Brg1 did not
compensate dnBrm1 activity (compare Fig. 6C, lane 6 with lane
2). A functional Brm1 ATPase activity was also required for the
redistribution of nucleoplasmic HP1β into nuclear foci [Fig. 6C,
compare HDAC1 induction at 2 days without (second panel)
and with (fourth panel) dnBrm1]. Finally, our results support and
Fig. 4 Induction of HDAC1 results in transient association of Brm1 with RB/HP1 complexes. (A) HDAC1 induces the association of HP1β with RB in nuclear 
foci. The boxes indicate areas zoomed to visualize the foci present in HDAC1-induced but not in control cells. The UCD-HDAC1 cells were treated as described 
in the legend of Fig. 3. (B) Western blot showing HDAC1 induction and concomitant changes in Brm1, RB, HDAC1, and HP1β protein levels. Immunoprecipitations 
with HP1β and HDAC1 antibodies suggest that large amounts of Brm1 are transiently associated with RB/HP1β complexes. (C) GST pull-down assays using 
extracts from proliferating (P) and senescent (S) melanocytes (see text for details). Upper panel: Increased association of HDAC1 with RB in senescent melanocytes. 
Middle panel: coomassie blue staining of total extracts (TE) and purified GST and GST-RB proteins. Bottom panel: GST-RB pulls down Brm1 from proliferating 
melanocytes whereas minimal levels are pulled down from senescent cultures. GST-NPC-RB and GST-LXCXE-RB were used as negative controls.HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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extend the notion that alterations in DNA-histone contacts are
regulated by the ATPase activity of SWI/SNF complexes resulting
in conformational changes within the nucleosome (Johnson
et al., 2005).
Discussion
The tumor suppressor Rb functions as a classical gatekeeper by
inducing irreversible growth arrest and senescence of potentially
cancerous cells (Kinzler & Vogelstein, 1997; Campisi, 2005;
Johnson et al., 2005). We have identified HDAC1 as a critical
mediator of chromatin remodeling events that take place prior
to overt senescence. Of most importance, our data suggest that
induction of HDAC1 may be a pivotal step in oncogene-induced
senescence of melanocytic nevi (Fig. 1).
Based on experiments described in this article, we propose
a model (Fig. 7) by which up-regulation of p16
INK4a triggers
RB dephosphorylation and recruitment of increased levels of
HDAC1. Changes in the stoichiometry and dynamics of RB
macromolecular complexes, by up-regulation of HDAC1 via
increased transcription and/or protein stabilization (Fig. 1), or
by increased use of the cell’s steady-state HDAC1 pool, in turn
initiate a chain of events leading to chromatin remodeling and
silencing of growth-promoting genes. At an early stage, reduction
of HDAC1 levels (Supplementary Fig. S1) will antagonize RB-
mediated repression and result in resumption of the cell cycle.
Conversely, severe, chronic HDAC1 overexpression will lead to
pervasive tethering of HP1β and RB with chromatin, hetero-
chromatin expansion and cellular senescence. Finally, this model
accounts for the results described herein, namely, overexpres-
sion of HDAC1 can overcome the loss of p16
INK4a and induce
senescence in human melanoma cells. Studies in progress are
aimed at determining the molecular mechanism(s) of HDAC1
up-regulation in melanocytic cells.
HDAC1 regulates multiple events leading to 
heterochromatinization
Gene silencing acts in a regional rather than promoter- or
sequence-specific manner to generate large DNA domains that
are inaccessible to DNA binding factors (Moazed, 2001). RB
repressive complexes transiently associate with chromatin during
cell cycle arrest (Angus et al., 2004). However, RB is strongly
and stably associated with chromatin in senescent cells (Fig. 2D).
Fig. 5 Formation of transient mega-complexes 
containing Brm1/RB/HP1β precedes growth 
inhibition. HPLC fractionation, Western blotting 
and coimmunoprecipitations of control cells 
(0 day) and cells induced to express HDAC1 for 
2 days or 3 weeks (see Experimental procedures). 
IP, immunoprecipitation.HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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Changes in the stoichiometry of RB/HDAC1 complexes result in
trimethylation of H3-K9, multiple HP1β foci and senescence
(Figs 2–4). Such changes are expected to be structurally differ-
ent from those observed in cells entering reversible quiescence
(Barbie et al., 2004), or after short-term (2 days) HDAC1 induction,
and associated with irreversible repression of E2F-regulated
genes including cyclins E and A via formation of E2F4/HDAC1/
RB complexes (Bandyopadhyay et al., 2002; Narita et al., 2003).
HDAC1 also induced a rapid relocalization of HP1β to DNA
foci and dimethylation of H3-K9 (Fig. 3), an event associated
Fig. 6 Brm1 ATPase activity is required for the association of RB and HP1β with chromatin and formation of HP1β foci. (A) Transient association of Brm1 but 
not Brg1 with chromatin 2 days after HDAC1 induction. (B) Transient expression of dnBrm1 prevented the association of RB and HP1β with chromatin. 
Transfection of wild-type Brg1, a highly homologous Brm1 protein, did not compensate dnBrm1 dominant negative activity. (C) dnBrm1 prevents formation 
of HP1β foci. UCD-HDAC1 cells were transiently transfected with pcDNA or dnBrm1. Cotransfection with a GFP-expressing plasmid was used to identify cells 
expressing an empty vector (pcDNA) or dnBrm1. After 8 h, cells were left untreated or treated with Dox for 2 days (to induce HDAC1). Coverslips were processed 
for immunofluorescence as described in Experimental procedures. The rectangular marquees indicate areas zoomed at the bottom to show that dnBrm1 curtails 
foci induced by HDAC1 (compare Fig. 6C second panel with Fig. 6C fourth panel).HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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with hypoacetylation in the coding regions of human genes
(Miao & Natarajan, 2005). As dimethylated H3-K9 is diffusely
scattered throughout silent euchromatin (Rice et al., 2003), our
data suggests that increased HDAC1 activity may expand such
compartments by switching active genes into silent euchromatin.
HP1 is transiently recruited to promyelocytic leukemia bodies
prior to its association with SAHF in human fibroblasts (Zhang
et al., 2005). The discrete number of HP1β foci observed 2 days
after HDAC1 induction suggest that these foci colocalize with
promyelocytic leukemia bodies (Hayakawa et al., 2003) as the
cells were still in the proliferative phase that preceded senes-
cence (Figs 1 and 2). Alternatively, early formation of HP1β
foci may be indicative of active chromatin reorganization in a
manner similar to the one observed during the final rounds or
replication that precede cell cycle exit triggered by nutrient
deprivation or after contact inhibition (Barbie et al., 2004). Such
cell cycle exit coincides with the reversible phase of cell cycle
arrest induced by HDAC1 (Supplementary Fig.  1C) and RB
(Angus et al., 2004).
Mammalian HP1β  forms stable complexes with SUV39H1
(Aagaard et al., 1999). In fact, SUV39H1 but not G9a, also an
H3-K9 methyltransferase, mediates the recruitment of HP1 to
chromatin (Stewart et al., 2005). In turn, the SET domain of
SUV39H1 appears to stabilize the association of SUV39H1 with
heterochromatin and also acts as a platform for the interaction
with other heterochromatin proteins. The reciprocal changes in
the localization of SUV39H1 and HP1β with chromatin (Fig. 3A)
suggest that HDAC1 facilitates the recruitment of these proteins
to chromatin (Krouwels et al., 2005). Future studies will address
whether the DNA methyltransferases including Dnmt1 and
Dnmt3a, which are known to associate with HP1 and SUV39H1
(Fuks et al., 2003), are also required for the reinforcement of
repressive chromatin in senescent cells.
Brm1 drives early localization of RB and HP1β β β β with 
chromatin and formation of HP1β β β β foci
SWI/SNF factors appear to influence higher-order chromatin
structures by several means including transferring the entire
core histone octamer to another region of DNA, disrupting
nucleosomes, changing nucleosome positioning, switching
between relaxed to condensed chromatin, bridging nucleo-
somes with 30 nm fibers, and/or attaching chromatin fibers to
nuclear structures such as the nuclear matrix or the nuclear
envelope (Varga-Weisz & Becker, 2006). We have identified
Brm1 as the likely engine required for the early association of
both HP1β and RB with chromatin, and formation of HP1β
foci (Fig. 6). We propose that Brm1 activity is necessary for the
incorporation of histone variants such as macroH2A into SAHF
(Zhang et al., 2005). This hypothesis is supported by data indi-
cating that the histone chaperone ASF1a, a critical component
in the generation of SAHF, cooperates with Brm1 chromatin-
remodeling activity (Moshkin et al., 2002).
Intriguingly, ejection of Brm1 from chromatin in senescent
cells (Fig.  6A) coincided with its dissociation from HP1β/RB
complexes (Fig.  4) and relocalization in complexes of lower
molecular weight (Fig. 5). So, why does not Brm1 bind to senes-
cent chromatin? The DNA binding stability of SWI/SNF com-
plexes is stimulated by the presence of hyperacetylated
nucleosomes (Hassan et al., 2001). Thus, a possible mechanism
for Brm1 eviction may be wide-spread hypoacetylation of
nucleosomes.
Brm1 cooperates with RB to repress E2F1 and induce complete
G1 arrest (Trouche et al., 1997). Intriguingly, the GST pull-down
assays demonstrated that RB does not bind Brm1 in senescent
cells (Fig. 4), an event that may be associated with the inter-
ference of macroH2A with transcription factor binding and SWI/
SNF nucleosome remodeling (Angelov et al., 2003). At the end,
Brm1 may become dispensable for maintenance of the irreversible
growth arrest once nucleosomes have been remodeled.
Fig. 7 Changes in the stoichiometry of RB/HDAC1 complexes regulate the 
onset of senescence. We propose a model by which up-regulation of p16
INK4a 
converts RB into its active, nonphosphorylated form which in turns recruits 
HDAC1, initiating a chain of dynamic chromatin events eventually leading to 
expansion of heterochromatin and cellular senescence (see text). A dotted 
arrow indicates that insertion of histone variants, changes in the nucleosome 
structure and yet to be defined molecular events including post-translational 
modifications of chromatin regulators contribute to the formation of stable 
heterochromatization and irreversibility of the senescent state.HDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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The significance of HDAC1 and Brm1 activities 
for senescence and aging phenotypes
Experimental evidence suggests that both HDAC1 and Rpd3 deace-
tylases play significant roles in aging and cancer. For example, HDAC1
stimulates angiogenesis in epithelial cells (Kim et al., 2001), an event
associated with retinal disease and other age-associated pathologies
(Gariano & Gardner, 2005), and generates hepatic steatosis in mice
(Wang et al., 2005), a pathological condition associated with
increased age, body weight, and fibrosis (Perumalswami et al., 2006).
Brm1 also plays a critical role in tissue aging by forming age-
specific repressive complexes containing RB, E2F4, and C/EBPα,
a liver transcription factor (Iakova et al., 2003). Evidence that Brm1
is crucial for the formation of this repressive complex includes
emergence of Brm1/RB/C/EBPα complexes in nuclear proteins
from young livers after incubation with excess Brm1, and reduction
of Brm1 levels from RB/C/EBPα complexes in old livers after hetero-
chronic parabiosis (Conboy et al., 2005).
In sum, our studies provide new mechanistic insights on early
events leading to the formation of RB/HDAC1/Brm1 complexes
and the onset of senescence in melanocytes and melanocytic nevi.
Our results also support the idea that adequate levels of chromatin
remodelers are required for maintaining both cell and tissue
homeostasis (Bandyopadhyay & Medrano, 2003; Saha & Pahan,
2006), as inhibition or activation of HATs or HDACs can induce
senescence in melanocytes (Bandyopadhyay et al., 2002; and this
communication), apoptosis of melanoma cells (Bandyopadhyay
et al., 2004) and neurodegeneration (Saha & Pahan, 2006).
Experimental procedures
Cell lines and antibodies
Neonatal human melanocytes were isolated and cultured in a
manner similar to that described previously (Schwahn et al., 2001).
The culture medium consists of MCDB-153 medium supplemented
with 1 ng mL
–1 recombinant human basic fibroblast growth factor,
5 µg mL
–1 insulin, 50 µg mL
–1 transferrin, 4% fetal bovine serum
(Sigma, St. Louis, MO, USA), 6.5 µg mL
–1 pituitary extract (Bio-
Whittaker, Walkersville, MD, USA), 10 nM cholera toxin, and 0.1 mM
3-isobutyl-1-methylxanthine. The UCD-Mel-N human melanoma
cell line (Garcia et al., 2004) and the derivative UCD-HDAC1 cells
were grown in D/F12 medium [equal amounts of Dulbecco’s
modified Eagle’s medium and F12 medium (Life Technologies,
Inc., Rockville, MD, USA)] with 1% antibiotic and antimycotic,
2.5 µg mL
–1 insulin, 25 µg mL
–1 transferrin, and 250 ng mL
–1 epi-
dermal growth factor supplemented with 8% fetal bovine serum.
The following primary antibodies were used: anti-RB antibody
(Labvision, Inc, Freemount, CA, USA); anti-HDAC1, antiacetylated
histones H3 and H4, antitotal histone H3 and H4 antibodies
(Upstate Inc, Lake Placid, NY, USA); anti-Brm1 antibody (BD
Transduction laboratories, San Diego, CA, USA); anti-HP1 antibodies
(Chemicon, Temecula, CA, USA); and anti-β-actin monoclonal
antibody (Sigma), all other antibodies were from Santa Cruz,
Inc. (Santa Cruz, CA, USA).
The Tet-inducible HDAC1 system
a. Selection of a UCD-Mel-N, Tet-On, G418-resistant cell line.
The UCD-Mel-N cells (Garcia et al., 2004) were stably trans-
fected with the rtTA-containing vector using FuGene6 transfection
reagent (Roche Applied Sciences, Indianapolis, IN, USA) and
800 µg mL
–1 neomycin (G418) as the selection marker. Clones
were tested for HDAC1 induction levels by transient transfection
of the pTRE-Luciferase plasmid (Clontech, Palo Alto, CA, USA).
Clones with high inducible luciferase activity were further
selected (designated as Tet-on-UCD) for construction of the
double transfectant containing the HDAC coding region under
the control of the tet-responsive element. b. Generation of
inducible Tet-On cell lines. A NheI-EcoRV fragment from pOZ-
HDAC1 (Humphrey et al., 2001) containing the coding region
of human HDAC1 was subcloned into the pTRE2-Hyg vector
(Clontech). The Tet-on UCD stable clones were selected for
resistance to 200 µg mL
–1 hygromycin. Thirty-five clones were
screened for HDAC1 expression. A clone displaying high HDAC1
levels was designated as UCD-HDAC1. Virtually identical results
were obtained with two additional clones. Clones expressing
empty pTRE-2-hyg vector were designated as UCD-control.
Expression of HDAC1, induced by adding 2 µg mL
–1 of Dox to
the culture medium, was followed for 2–3 days or 3 weeks.
The culture medium containing Dox was changed three times
per week.
Cell growth rates 
An MTT-assay kit (Roche Applied Science) was used to deter-
mine the effect of HDAC1 induction on cell growth. Briefly,
1 × 10
3 cells of UCD-HDAC1 or UCD-control were seeded on
12-well plates and were treated with 2 µg mL
–1 of Dox (or left
untreated) for increasing time. The MTT assays were performed
every other day.
Immunofluorescence 
The cells grown in glass coverslips were washed twice with
phosphate-buffered saline (PBS), fixed in 70  :  30 methanol  :
acetone mixture for 30 min at –20 °C, and blocked with TBS-
T (20 mM Tris, 150 mM NaCl, and 0.2% Tween-20) + 5% nonfat
dry milk at 37 °C for 1 h. Incubation with the appropriate
polyclonal or monoclonal antibody was performed at 37 °C for
1 h followed by three washes with TBS-T and incubation with
an antirabbit secondary antibody conjugated with tetramethyl-
rhodamine isothiocyanate or with an antimouse antibody
conjugated with FITC (Santa Cruz) at 37 °C for 1 h. After a final
wash, the slides were mounted with antifade mounting media
(Vector Laboratories, Burlingame, CA, USA) and visualized under
a fluorescence microscope.
Immunoblotting, immunoprecipitation, and 
expression of senescent-associated β β β β-galactosidase
Equal amounts (50 µg) of whole cell lysates were electrophoresed
in sodium dodecyl sulfate–polyacrylamide gel electrophoresisHDAC1 complexes regulate melanocyte senescence, D. Bandyopadhyay et al.
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(SDS-PAGE) and transferred to nitrocellulose membranes.
Membranes were washed with TBS-T (TBS + 0.5% Tween-20),
blocked with 5% milk in TBS-T for 1 h at room temperature,
and incubated overnight at 4 °C in TBS-T containing appropriate
dilutions of primary antibodies. The membranes were then
washed three times and incubated with a horseradish peroxi-
dase-conjugated donkey antirabbit or sheep antimouse IgG
antibody (1 : 3000) in TBS-T for 1 h at room temperature. After
washing, the target proteins were detected using an enhanced
chemiluminescence immunoblotting detection kit (GE Health
Care, Piscataway, NJ, USA). For immunoprecipitation, 600 µg
of total cell extracts were incubated with an appropriate anti-
body at 4 °C for 3 h. Protein G or protein A-Sepharose beads
were used to immobilize the antibody complex. The Sepharose-
bound immunocomplexes were washed three times with 10
volumes of lysis buffer, boiled in SDS-Laemmli sample buffer,
and electrophoresed in SDS-PAGE gels. SA-β-Gal activity was
determined as described previously (Dimri et al., 1995).
Immunohistochemistry 
Five-µm thick formalin-fixed paraffin-embedded melanocytic
nevi samples were derived from the tissue archives of the Section
of Dermatopathology, Department of Pathology, Baylor College
of Medicine. Tissue sections were deparaffinized, rehydrated in
ethanol, and subject to heat induced antigen microwave retrieval
(10 mM citrate buffer pH 6.0; microwaving; 15 min). Deparaffi-
nized sections were incubated with the following antibodies:
polyclonal anti-HDAC1 (dilution 1 : 50, Santa Cruz), monoclonal
anticyclin A (dilution 1 : 10), monoclonal anti-p16
INK4a (dilution
1 : 400), monoclonal anti-Melan A (dilution 1 : 1000) (all from
Labvision) in a buffer containing 0.1% bovine serum albumin
for 1 h at room temperature. Subsequent immunostaining was
performed using the avidin-biotin immunoperoxidase technique
following the manufacturer’s instruction (Vectastain, Vector
Laboratories). Color development with the chromogen 3-amino-
9-ethyl carbazole produced a positive red reaction product;
hematoxylin was used as a counterstain.
Histone isolation and fractionation
Histones were isolated by the acid extraction method as described
previously (Zweidler, 1978). Isolated histones were fractionated
in 15% polyacrylamide gels.
Expression and purification of GST proteins
GST-tagged RB and its mutant forms were propagated in
BL21DE3 (pLysE) cells. Expression and purification of GST proteins
were performed using a commercially available GST purification
kit (GE Healthcare). For GST pull-down assays, 400 µg of total
bacterial lysate containing the GST-tagged protein were incu-
bated with pre-equilibrated glutathione sepharose CL-4B beads
at room temperature for 2 h. The immobilized proteins were
washed with PBS and incubated with UCD or melanocyte cell
extracts for 2 h at 4 ºC. The protein complexes were washed
with NP-40 lysis buffer and analyzed in SDS-PAGE followed by
immunoblotting.
Protein fractionation by size exclusion chromatography 
Nuclear extracts were obtained by gentle lysis of cells in buffer
A (10 mM Tris–HCl pH 7.5, 150 mM NaCl, 1.5 mM MgCl2, and
10 mM EDTA), followed by rupturing the nuclei in high salt-
containing buffer B (10  mM  Tris–HCl pH  7.5, 420  mM  NaCl,
1.5 mM MgCl2, 0.5 mM EDTA, and 1 mM DTT). The nuclear extracts
were analyzed by size exclusion column SEC-400 (HPLC, Bio-
logic HR; Bio-Rad, Hercules, CA, USA). The individual fractions
were separated by SDS-PAGE and detected by immunoblotting.
For multiprotein complex identification, the fractions were
diluted to adjust the NaCl concentration to 120 mM followed
by immunoprecipitation with the indicated antibodies.
Isolation of chromatin and analysis of heterochromatin 
formation 
UCD-HDAC1 cells were induced with 2 µg mL
–1 Dox for 0 day,
3 days, or 3 weeks. The cells on the plate were washed with
PBS and overlayed with 2 mL of micrococcal nuclease buffer
(250 mM sucrose, 10 mM Tris–HCl pH 7.5, 10 mM NaCl, 3 mM
MgCl2, 0.1 mM PMSF, and 1 mM CaCl2) with 60 U mL
–1 micro-
coccal nuclease (Worthington Biochemical Corp., Freehold, NJ,
USA) and kept at room temperature for 6 min. The duration of
digestion was adjusted to generate a chromatin preparation
with a size range of 146 bp–2 kbp. The reaction was stopped
by addition of 5 mM EDTA and the cells were promptly har-
vested. Nuclei were lysed in 10  mM  Tris–HCl, 10  mM  NaCl,
0.2 mM EDTA, and 0.1 mM PMSF. The resulting suspension
was centrifuged at 16 000 g for 10 min; the supernatant
containing the chromatin fraction (oligonucleosomes) was
electrophoresed in 1.5% agarose gel.
In vitro binding of HP1β in chromatin
HP1β was immunopurified from cells using a polyclonal HP1β
antibody (Santa Cruz). Sepharose bound HP1β was then mixed
with the chromatin fraction using HEPES buffer (10 mM HEPES
pH 7.3, 20 mM NaCl, 0.5 mM EGTA, 10% glycerol, and 1 mM DTT)
and incubated for 1 h at room temperature. The beads were
washed with HEPES buffer followed by proteinase K protein
degradation. The HP1β-bound DNA was recovered from beads
by phenol : chloroform extraction and alcohol precipitation. The
recovered DNA was analyzed in 1.5% agarose gels. In vivo HP1β-
chromatin binding: the micrococcal digested oligonucleosomal
preparation was subjected to DEAE-Sephacel chromatography
to exclude the nuclear proteins that are not bound to DNA. After
DNA degradation by DNase 1, proteins were analyzed by SDS-
PAGE and immunoblotting with an anti-HP1β antibody.
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Supplementary material
The following supplementary material is available for this article:
Fig. S1 Irreversibility of the senescent state induced by HDAC1.
(A) Induction of HDAC1 protein (see Fig. 1B) results in increased
HDAC1 activity. (B) HDAC1 overexpression results in progressive
loss of DNA synthesis. (C) Short-term induction of HDAC1 does
not cause growth arrest. UCD-HDAC1 cells were seeded in p35-
mm plastic dishes, left untreated, treated with 2 µg mL
–1 Dox
to induce HDAC1 for 2 days, or treated with Dox for 2 days
followed by removal of the drug for 8 days. SA-β-gal staining
(Dimri et al., 1995) was negative in all three conditions. Removal
of Dox allowed the cells to proliferate without evident signs of
growth alterations or phenotypic changes in their morphology.
(D) Long-term induction results in irreversible growth arrest and
senescence. Cells treated with Dox for 3 weeks displayed large
cells with transparent cytoplasm and were SA-β-gal-positive.
Removal of Dox for 8 days did not result in changes of the flat
morphology or induce significant proliferation. The cells were
fixed with formaldehyde and stained with crystal violet. (E) The
telomerase repeat amplification protocol (TRAP) previously
described (Suwa et al., 2001) was used to measure telomerase
activity before and after induction of HDAC1 in UCD cells. Two
different primary cultures of human normal proliferating
melanocytes [NHM (1) and NHM (2)] were used as negative
controls.
Experimental procedures
HDAC1 activity assay. Cell extracts from UCD-wild-type or
UCD-HDAC1 were used to determine RB-associated HDAC
activity (HDAC assay kit; Upstate). A SGRGKGGKGLGKG-
GAKRHRKVLR peptide substrate was prelabeled with [
3H]-sodium
acetate using benzotriazol-1-yloxytris-(dimethylamino)-phosphonium
hexafluoruphosphate. The immunoprecipitates were incubated
with the labeled peptide overnight at room temperature.
Radioactivity released by the labeled peptide (HDAC activity)
was measured after ethyl-acetate extraction.
BrdU labeling. The BrdU activity assay was performed using a
commercially available kit from Roche Applied Sciences. Briefly,
UCD-HDAC1 and UCD-wild-type cells were seeded on coverslips
and treated with or without 2 µg mL
–1 doxycyclin for the time
indicated in the figures. Afterwards, the cells were incubated
with 1 : 1000 dilution of BrdU in the fresh medium and the
percent of positive cells determined by immunocytochemistry
using an anti-BrdU monoclonal antibody provided by the
manufacturer.
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Fig. S2 Normal human senescent melanocytes display
increased HP1β foci. Left panel: proliferating melanocytes dis-
play nucleoplasmic distribution of HP1β. Right panel: HP1β is
mostly redistributed in nuclear foci in senescent cells.
Experimental procedures
Cells were fixed with 10% formaldehyde, washed with PBS con-
taining 0.05% Tween-20 (PBS-T), and permeabilized in 1% Triton
X-100 in PBS for 20 min. After incubation with a blocking buffer
(5% bovine serum albumin in PBS), the cells were exposed to
anti-HP1β antibody (monoclonal antibody 3448, CHEMICON)
followed by incubation with Alexa Fluor Alexa Fluor 488
(Invitrogen; Molecular Probes, Eugene, OR, USA) secondary anti-
bodies. After a final wash, the slides were mounted with antifade
mounting media containing DAPI (H-1200, Vector Laboratories)
and observed with an inverted fluorescence microscope.
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